Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to rule out a greater than 10% incidence of hypersensitivity
to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or
equal to 10% hypersensitivity response was considered acceptable.